News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
New breast cancer test links immune ‘hotspots’ to better survival
From criminology to cancer research – a new test can predict the survival chances of women with breast cancer by analysing images of ‘hotspots’ where there has been a fierce immune reaction to a tumour.
Scientists find cancer weak spots for new targeted drugs
Scientists have identified weak spots in cancer cells that could be targeted and attacked by new precision drugs.
Cancer risk linked to DNA ‘wormholes’
Researchers found that DNA sequences within ‘gene deserts’ – so called because they are completely devoid of genes – can regulate gene activity elsewhere by forming DNA loops across relatively large distances.
Why we need more women at the top of science
Despite making up 50% of students and postdoctoral researchers, not enough women progress to senior positions in science. The ICR is striving to ensure all researchers have the same opportunities to develop their scientific careers, regardless of gender.
Scan tunes out interference to detect cancer metabolism
A new type of scan uses a clever ‘noise cancelling’ technique to map cancer metabolism inside brain tumours, a new study shows.
Paul Workman visits Boston with London Mayor Boris Johnson
Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, visited the prestigious university town of Boston this week with Mayor of London Boris Johnson to promote the capital as a world-leading centre for life sciences.
Statement on today’s rejection of abiraterone before chemotherapy by the Scottish Medicines Consortium
The ICR's CEO Professor Paul Workman reacts to the news that the Scottish Medicines Consortium has rejected the use of abiraterone before chemotherapy.
ICR and The Royal Marsden to star in BBC Panorama documentary
An episode of Panorama focused entirely on the pioneering work of The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust is to air on BBC One next week.
Two major studies strengthen case for prostate cancer drug before chemotherapy
Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.
Major study links two new genetic variants to breast cancer
A worldwide study of the DNA of 100,000 women has discovered two new genetic variants associated with an increased risk of breast cancer. The genetic variants are specifically linked to the most common form of breast cancer, oestrogen receptor positive, and provide important insights into how the disease develops.
Simple tweak to MRI could sharpen images of cancers
A simple change in the processing of data from scans of cancer patients could sharpen images taken of tumours, a new study reveals.
Universities must support networking for women in science, says Professor Paul Workman
Universities must offer women more networking opportunities and training in leading large teams to help close the gender gap at the top of science – according to the head of the UK’s leading research centre. Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, urged more support for female scientists to lead ‘team science’ initiatives in a roundtable discussion at the Academy of Medical Sciences today (Monday).
